The Translational Research Institute (TRI) has awarded six UAMS researchers approximately $50,000 each for pilot studies. The annual awards are made to those studies with the strongest likelihood of leading to improved health and health care. The researchers and their project titles are:

Paul Gottschall, Ph.D., College of Medicine (COM), Department of Pharmacology and Toxicology: Targeting lecticans to enhance synaptic plasticity in Alzheimer’s disease
Gur Kaushal, Ph.D., COM, Department of Internal Medicine: Antifibrotic therapy by upregulation of autophagy to reverse renal fibrosis in chronic kidney disease
Dennis Kuo, M.D., COM, Department of Pediatrics: Barriers and facilitators to health care transition from pediatric to adult health care
Lee Ann MacMillan-Crow, Ph.D., COM, Department of Pharmacology and Toxicology: Novel therapy to reduce injury to human donor kidneys prior to transplant
Mark Mennemeier, Ph.D., COM, Department of Neurobiology & Developmental Sciences: A joint CTSA (Clinical and Translational Science Award) project with WUSM (Washington University School of Medicine, St. Louis) leading to a phase II clinical trial for tinnitus
Steven Post, Ph.D., COM, Department of Pathology: Pathological features that predict clinical outcome in vulvar squamous cell carcinoma patients
TRI utilizes National Institutes of Health (NIH) Study Section review criteria in making its selections. Reviewers are not involved in the review and scoring of applications where potential conflicts of interest exist.